ALPHA TAU MEDICAL LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.5 USD | +2.46% |
|
-8.56% | -16.94% |
Financials (USD)
| Sales 2024 * | 75K | Sales 2025 * | 1.37M | Capitalization | 170M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2,267 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 124 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 121 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.28% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +2.46% | ||
| 1 week | -8.56% | ||
| Current month | -15.25% | ||
| 1 month | -14.38% | ||
| 3 months | -16.94% | ||
| 6 months | -24.92% | ||
| Current year | -16.94% |
1 week
2.41
2.86
1 month
2.413.06
Current year
2.413.40
1 year
2.414.80
3 years
2.4120.65
5 years
2.4120.65
10 years
2.4120.65
| Managers | Title | Age | Since |
|---|---|---|---|
Itzhak Kelson
FOU | Founder | 84 | 15-10-31 |
Yona Keisari
FOU | Founder | 76 | 15-10-31 |
Uzi Sofer
CEO | Chief Executive Officer | 54 | 15-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Milch
BRD | Director/Board Member | 68 | 22-02-28 |
Meir Jakobsohn
BRD | Director/Board Member | 54 | 15-12-31 |
Alan Adler
BRD | Director/Board Member | 57 | 17-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 2.5 | +2.46% | 43 419 |
| 24-04-22 | 2.44 | -4.69% | 124,885 |
| 24-04-19 | 2.56 | -3.76% | 47,779 |
| 24-04-18 | 2.66 | -1.12% | 101,304 |
| 24-04-17 | 2.69 | -1.61% | 27,007 |
Delayed Quote Nasdaq, April 23, 2024 at 03:58 pm EDT
More quotes
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Sector
Investment Holding Companies
Calendar
2024-05-21
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.44
USD
Average target price
9.25
USD
Spread / Average Target
+279.10%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.94% | 170M | |
| +85.94% | 4.85B | |
| +1.60% | 1.01B | |
| +2.29% | 981M | |
| +41.91% | 872M | |
| +30.50% | 851M | |
| +1.63% | 663M | |
| +0.54% | 610M | |
| -.--% | 600M | |
| +22.16% | 542M |
- Stock Market
- Equities
- DRTS Stock
